# A Study of Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery

> **NCT07225140** · PHASE3 · NOT_YET_RECRUITING · sponsor: **AFT Pharmaceuticals, Ltd.** · enrollment: 180 (estimated)

## Conditions studied

- Post Operative Pain, Acute

## Interventions

- **DRUG:** Combogesic® tablets
- **DRUG:** Acetaminophen 500mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07225140
- **Lead sponsor:** AFT Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07225140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07225140, "A Study of Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT07225140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*